SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-029536
Filing Date
2019-02-06
Accepted
2019-02-06 16:08:01
Documents
2
Group Members
ARNOLD L. ORONSKYGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS X, LLCKEVAL DESAIKHALED A. NASR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d700095dsc13da.htm SC 13D/A 135205
2 EX-99.A d700095dex99a.htm EX-99.A 6009
  Complete submission text file 0001193125-19-029536.txt   142948
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87931 | Film No.: 19571640
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025
Business Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025 650-854-8585
INTERWEST PARTNERS X LP (Filed by) CIK: 0001443898 (see all company filings)

IRS No.: 263131621
Type: SC 13D/A